126
|
Qiu X, Zheng SL, Wang Y, Wang R, Ye L. A Rapid and Simple UPLC-MS-MS Method for Determination of Glipizide in Human Plasma and Its Application to Bioequivalence Study. J Chromatogr Sci 2014; 53:85-9. [DOI: 10.1093/chromsci/bmu023] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
127
|
Rey F, Huang S, O’Sullivan B, Qiu X, Wei X, Chan B, Ringash J, Goldstein D, Kim J, Waldron J. EP-1136: Definitive radiation therapy for advanced stage oral cavity squamous cell carcinoma (OCSCC). Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31254-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
128
|
Carlson R, Hiemstra K, Pearson S, Qiu X, Xu W, Fyles A, Chung C. Abstract P5-14-15: Discovery and validation of simple heart measurements to screen patients who will benefit from deep inspiration breath hold for left breast irradiation. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p5-14-15] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Purpose:
Deep inspiration breath hold (DIBH) using active breath control in left-sided breast irradiation (RT) can significantly reduce radiation dose to heart and coronary arteries in selected patients. At our institution, a cutoff of V50% >10cc is currently used to identify patients who require DIBH. This dose-volume cutoff requires generation of a radiation plan in order to select patients. The purpose of this study was to identify simple 2-D measurements of the heart at the time of CT simulation that can help screen patients for DIBH in order to streamline the process for left-sided breast RT.
Methods:
This study evaluated CT simulation scans from 50 left-sided breast cancer patients treated with tangent RT alone, where 50% of patients were treated with DIBH. On each CT dataset, a tangential line was drawn between the medial and lateral tattoos. The following heart measurements were recorded by a blinded observer at 2, 3, 4, and 5 cm below the tattoos: (1) maximal heart distance (MHD) perpendicular to this line and (2) heart length (HL) along this line. Predictive models were created using two strategies; (1) step wise approach utilizing the most significant factor and (2) principle component analysis. Using C-statistics, 3 cutoffs with the highest correlations with heart dose were determined from the model. These cutoffs were validated in a cohort of 100 consecutive patients treated from Jan-May 2012.
Results:
Data from 49 patients in the derivation cohort were analyzable. The HL at 2 cm had the strongest correlation with V50 (R2 = 0.45; p <0.0001). Other values that were associated with V50 were HL at 3 cm (R2 = 0.37; p = <0.0001), MHD at 2cm (R2 = 0.25; p = 0.0003), MHD at 3 cm (R2 = 0.23; p = 0.0006) and HL at 4 cm (R2 = 0.17, p = 0.0035). The predictive model using HL at 2 cm gave an adjusted R2 = 0.4385 (P<0.0001). Adding other variables into the predictive model did not improve the adjusted R2. The following 3 cutoffs for HL at 2 cm with respective (sensitivity; specificity) were identified: 3.92 cm (0.955; 0.48), 7.65 cm (0.32; 0.48), and 6.5 cm (0.5; 0.8). In the validation cohort, 22/100 had V50% > 10 cc. Validation of the 3 derived cutoffs for HL at 2 cm yielded the following sensitivities and specificities: 1.0 and 0.28 for 3.92 cm; 0.53 and 0.93 for 7.65 cm; 0.58 and 0.69 for 6.5 cm. Positive predictive value (PPV) and negative predictive value (NPV) were as follows: 3.92 cm (PPV = 0.25; NPV = 1.00). 7.65 cm (PPV = 0.63; NPV = 0.89), and 6.5cm (PPV = 0.30; NPV = 0.87).
Conclusions:
A simple 2-D heart measurement, heart length at 2 cm below the tattoos, had moderate correlation with the irradiated heart volume. Although HL at 2 cm did not have both high specificity and sensitivity to predict who would benefit from DIBH, cut-offs could be selected to maximize sensitivity (3.92 cm for sensitivity 1.0) or specificity (7.65 cm for specificity 0.93). For example, in departments that routinely acquire both free-breathing and DIBH CT simulation scans for all left-sided patients, a cutoff of 3.92cm would minimize the number of unnecessary DIBH scans.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P5-14-15.
Collapse
|
129
|
Ferretti L, Qiu X, Villalta J, Lin G. Comparaison de l’efficacité de différentes compresses hémostatiques sur un model de néphrectomie partielle et de plaie aortique chez le rat. Prog Urol 2013. [DOI: 10.1016/j.purol.2013.08.199] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
130
|
Campian J, Gladstone D, Ambady P, Ye X, King K, Borrello I, Petrik S, Golightly M, Holdhoff M, Grossman S, Bhardwaj R, Chakravadhanula M, Ozols V, Georges J, Carlson E, Hampton C, Decker W, Chiba Y, Hashimoto N, Kagawa N, Hirayama R, Tsuboi A, Oji Y, Oka Y, Sugiyama H, Yoshimine T, Choi B, Gedeon P, Herndon J, Sanchez-Perez L, Mitchell D, Bigner D, Sampson J, Choi YA, Pandya H, Gibo DM, Debinski W, Cloughesy TF, Liau LM, Chiocca EA, Jolly DJ, Robbins JM, Ostertag D, Ibanez CE, Gruber HE, Kasahara N, Vogelbaum MA, Kesari S, Mikkelsen T, Kalkanis S, Landolfi J, Bloomfield S, Foltz G, Pertschuk D, Everson R, Jin R, Safaee M, Lisiero D, Odesa S, Liau L, Prins R, Gholamin S, Mitra SS, Richard CE, Achrol A, Kahn SA, Volkmer AK, Volkmer JP, Willingham S, Kong D, Shin JJ, Monje-Deisseroth M, Cho YJ, Weissman I, Cheshier SH, Kanemura Y, Sumida M, Yoshioka E, Yamamoto A, Kanematsu D, Takada A, Nonaka M, Nakajima S, Goto S, Kamigaki T, Takahara M, Maekawa R, Shofuda T, Moriuchi S, Yamasaki M, Kebudi R, Cakir FB, Gorgun O, Agaoglu FY, Darendeliler E, Lin Y, Wang Y, Qiu X, Jiang T, Lin Y, Wang Y, Jiang T, Zhang G, Wang J, Okada H, Butterfield L, Hamilton R, Drappatz J, Engh J, Amankulor N, Lively M, Chan M, Salazar A, Potter D, Shaw E, Lieberman F, Pandya H, Choi Y, Park J, Phuphanich S, Wheeler C, Rudnick J, Hu J, Mazer M, Wang H, Nuno M, Guevarra A, Sanchez C, Fan X, Ji J, Chu R, Bender J, Hawkins E, Black K, Yu J, Reap E, Archer G, Sanchez-Perez L, Norberg P, Schmittling R, Nair S, Cui X, Snyder D, Chandramohan V, Choi B, Kuan CT, Mitchell D, Bigner D, Yan H, Sampson J, Reardon D, Li G, Recht L, Fink K, Nabors L, Tran D, Desjardins A, Chandramouli N, Duic JP, Groves M, Clarke A, Hawthorne T, Green J, Yellin M, Sampson J, Rigakos G, Spyri O, Nomikos P, Stavridi F, Grossi I, Theodorakopoulou I, Assi A, Kouvatseas G, Papadopoulou E, Nasioulas G, Labropoulos S, Razis E, Rudnick J, Ravi A, Sanchez C, Tang DN, Hu J, Yu J, Sharma P, Black K, Sengupta S, Sampath P, Soto H, Erickson K, Malone C, Hickey M, Ha E, Young E, Ellingson B, Prins R, Liau L, Kruse C, Sul J, Hilf N, Kutscher S, Schoor O, Lindner J, Reinhardt C, Kreisl T, Iwamoto F, Fine H, Singh-Jasuja H, Teijeira L, Gil-Arnaiz I, Hernandez-Marin B, Martinez-Aguillo M, Sanchez SDLC, Viudez A, Hernandez-Garcia I, Lecumberri MJ, Grandez R, de Lascoiti AF, Garcia RV, Thomas A, Fisher J, Baron U, Olek S, Rhodes H, Gui J, Hampton T, Tafe L, Tsongalis G, Lefferts J, Wishart H, Kleen J, Miller M, Ernstoff M, Fadul C, Vlahovic G, Desjardins A, Peters K, Ranjan T, Herndon J, Friedman A, Friedman H, Bigner D, Archer G, Lally-Goss D, Sampson J, Wainwright D, Dey M, Chang A, Cheng Y, Han Y, Lesniak M, Weller M, Kaulich K, Hentschel B, Felsberg J, Gramatzki D, Pietsch T, Simon M, Westphal M, Schackert G, Tonn JC, Loeffler M, Reifenberger G, Yu J, Rudnick J, Hu J, Phuphanich S, Mazer M, Wang H, Xu M, Nuno M, Patil C, Chu R, Black K, Wheeler C. IMMUNOTHERAPY/BIOLOGICAL THERAPIES. Neuro Oncol 2013; 15:iii68-iii74. [PMCID: PMC3823893 DOI: 10.1093/neuonc/not178] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/09/2023] Open
|
131
|
Adamson P, Barr G, Bishai M, Blake A, Bock GJ, Bogert D, Cao SV, Cherdack D, Childress S, Coelho JAB, Corwin L, Cronin-Hennessy D, de Jong JK, Devan AV, Devenish NE, Diwan MV, Escobar CO, Evans JJ, Falk E, Feldman GJ, Frohne MV, Gallagher HR, Gomes RA, Goodman MC, Gouffon P, Graf N, Gran R, Grzelak K, Habig A, Hartnell J, Hatcher R, Himmel A, Holin A, Hylen J, Irwin GM, Isvan Z, James C, Jensen D, Kafka T, Kasahara SMS, Koizumi G, Kordosky M, Kreymer A, Lang K, Ling J, Litchfield PJ, Lucas P, Mann WA, Marshak ML, Mathis M, Mayer N, Medeiros MM, Mehdiyev R, Meier JR, Messier MD, Miller WH, Mishra SR, Moed Sher S, Moore CD, Mualem L, Mufson S, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nowak JA, Oliver WP, Orchanian M, Pahlka RB, Paley J, Patterson RB, Pawloski G, Phan-Budd S, Plunkett RK, Qiu X, Radovic A, Rebel B, Rosenfeld C, Rubin HA, Sanchez MC, Schneps J, Schreckenberger A, Schreiner P, Sharma R, Sousa A, Tagg N, Talaga RL, Thomas J, Thomson MA, Toner R, Torretta D, Tzanakos G, Urheim J, Vahle P, Viren B, Weber A, Webb RC, White C, Whitehead L, Wojcicki SG, Zwaska R. Search for flavor-changing non-standard neutrino interactions by MINOS. Int J Clin Exp Med 2013. [DOI: 10.1103/physrevd.88.072011] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
132
|
Ke S, Wang W, Qiu X, Zhang F, Yustein JT, Cameron AG, Zhang S, Yu D, Zou C, Gao X, Lin J, Yallampalli S, Li M. Multiple target-specific molecular agents for detection and image analysis of breast cancer characteristics in mice. Curr Mol Med 2013; 13:446-58. [PMID: 23331017 PMCID: PMC3636521 DOI: 10.2174/1566524011313030014] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2012] [Revised: 10/12/2012] [Accepted: 10/15/2012] [Indexed: 01/25/2023]
Abstract
Breast cancer is a heterogenetic tumor at the cellular level with multiple factors and components. The inconsistent expression of molecular markers during disease progression reduces the accuracy of diagnosis and efficacy of target-specific therapy. Single target-specific imaging agents can only provide limited tumor information at one time point. In contrast, multiple target-specific imaging agents can increase the accuracy of diagnosis. The aim of this study was to demonstrate the ability of multi-agent imaging to discriminate such differences in single tumor. Mice bearing human cancer cell xenografts were tested to determine individual differences under optimal experimental conditions. Neovasculature agent (RGD peptide), tumor stromal agent (matrix metalloproteinase), and tumor cell markers (epidermal growth factor, Her-2, interleukin 11) imaging agents were labeled with reporters. 18F-Fluorodeoxyglucose was used to evaluate the tumor glucose status. Optical, X-ray, positron emission tomography, and computer tomography imaging modalities were used to determine tumor characteristics. Tumor size and imaging data demonstrated that individual differences exist under optimal experimental conditions. The target-specific agents used in the study bind to human breast cancer cell lines in vitro and xenografts in vivo. The pattern of binding corresponds to that of tumor markers. Multi-agent imaging had complementary effects in tumor detection. Multiple noninvasive imaging agents and modalities are complementary in the interrogation of unique biological information from each individual tumor. Such multi-agent approaches provide methods to study several disease components simultaneously. In addition, the imaging results provide information on disease status at the molecular level.
Collapse
|
133
|
Qiu X, Cao L, Yang X, Zhao X, Liu X, Han Y, Xue Y, Jiang H, Chi Z. Role of mitochondrial fission in neuronal injury in pilocarpine-induced epileptic rats. Neuroscience 2013; 245:157-65. [DOI: 10.1016/j.neuroscience.2013.04.019] [Citation(s) in RCA: 45] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2013] [Revised: 03/18/2013] [Accepted: 04/03/2013] [Indexed: 12/18/2022]
|
134
|
Adamson P, Anghel I, Backhouse C, Barr G, Bishai M, Blake A, Bock GJ, Bogert D, Cao SV, Castromonte CM, Childress S, Coelho JAB, Corwin L, Cronin-Hennessy D, de Jong JK, Devan AV, Devenish NE, Diwan MV, Escobar CO, Evans JJ, Falk E, Feldman GJ, Frohne MV, Gallagher HR, Gomes RA, Goodman MC, Gouffon P, Graf N, Gran R, Grzelak K, Habig A, Hahn SR, Hartnell J, Hatcher R, Himmel A, Holin A, Hylen J, Irwin GM, Isvan Z, James C, Jensen D, Kafka T, Kasahara SMS, Koizumi G, Kordosky M, Kreymer A, Lang K, Ling J, Litchfield PJ, Lucas P, Mann WA, Marshak ML, Mathis M, Mayer N, McGowan AM, Medeiros MM, Mehdiyev R, Meier JR, Messier MD, Michael DG, Miller WH, Mishra SR, Moed Sher S, Moore CD, Mualem L, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nowak JA, O'Connor J, Oliver WP, Orchanian M, Pahlka RB, Paley J, Patterson RB, Pawloski G, Phan-Budd S, Plunkett RK, Qiu X, Radovic A, Rebel B, Rosenfeld C, Rubin HA, Sanchez MC, Schneps J, Schreckenberger A, Schreiner P, Sharma R, Sousa A, Tagg N, Talaga RL, Thomas J, Thomson MA, Tinti G, Tognini SC, Toner R, Torretta D, Tzanakos G, Urheim J, Vahle P, Viren B, Weber A, Webb RC, White C, Whitehead L, Whitehead LH, Wojcicki SG, Zwaska R. Measurement of neutrino and antineutrino oscillations using beam and atmospheric data in MINOS. PHYSICAL REVIEW LETTERS 2013; 110:251801. [PMID: 23829728 DOI: 10.1103/physrevlett.110.251801] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/23/2013] [Indexed: 06/02/2023]
Abstract
We report measurements of oscillation parameters from ν(μ) and ν(μ) disappearance using beam and atmospheric data from MINOS. The data comprise exposures of 10.71×10(20) protons on target in the ν(μ)-dominated beam, 3.36×10(20) protons on target in the ν(μ)-enhanced beam, and 37.88 kton yr of atmospheric neutrinos. Assuming identical ν and ν oscillation parameters, we measure |Δm2| = (2.41(-0.10)(+0.09))×10(-3) eV2 and sin2(2θ) = 0.950(-0.036)(+0.035). Allowing independent ν and ν oscillations, we measure antineutrino parameters of |Δm2| = (2.50(-0.25)(+0.23))×10(-3) eV2 and sin2(2θ) = 0.97(-0.08)(+0.03), with minimal change to the neutrino parameters.
Collapse
|
135
|
Adamson P, Anghel I, Backhouse C, Barr G, Bishai M, Blake A, Bock GJ, Bogert D, Cao SV, Cherdack D, Childress S, Coelho JAB, Corwin L, Cronin-Hennessy D, de Jong JK, Devan AV, Devenish NE, Diwan MV, Escobar CO, Evans JJ, Falk E, Feldman GJ, Frohne MV, Gallagher HR, Gomes RA, Goodman MC, Gouffon P, Graf N, Gran R, Grzelak K, Habig A, Hahn SR, Hartnell J, Hatcher R, Himmel A, Holin A, Hylen J, Irwin GM, Isvan Z, Jaffe DE, James C, Jensen D, Kafka T, Kasahara SMS, Koizumi G, Kordosky M, Kreymer A, Lang K, Ling J, Litchfield PJ, Lucas P, Mann WA, Marshak ML, Mathis M, Mayer N, Medeiros MM, Mehdiyev R, Meier JR, Messier MD, Michael DG, Miller WH, Mishra SR, Moed Sher S, Moore CD, Mualem L, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nowak JA, Ochoa-Ricoux JP, O'Connor J, Oliver WP, Orchanian M, Pahlka RB, Paley J, Patterson RB, Pawloski G, Phan-Budd S, Plunkett RK, Qiu X, Radovic A, Rebel B, Rosenfeld C, Rubin HA, Sanchez MC, Schneps J, Schreckenberger A, Schreiner P, Sharma R, Sousa A, Tagg N, Talaga RL, Thomas J, Thomson MA, Tinti G, Toner R, Torretta D, Tzanakos G, Urheim J, Vahle P, Viren B, Weber A, Webb RC, White C, Whitehead L, Wojcicki SG, Yang T, Zwaska R. Electron neutrino and antineutrino appearance in the full MINOS data sample. PHYSICAL REVIEW LETTERS 2013; 110:171801. [PMID: 23679706 DOI: 10.1103/physrevlett.110.171801] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/22/2013] [Revised: 02/24/2013] [Indexed: 06/02/2023]
Abstract
We report on ν(e) and ν(e) appearance in ν(μ) and ν(μ) beams using the full MINOS data sample. The comparison of these ν(e) and ν(e) appearance data at a 735 km baseline with θ13 measurements by reactor experiments probes δ, the θ23 octant degeneracy, and the mass hierarchy. This analysis is the first use of this technique and includes the first accelerator long-baseline search for ν(μ) → ν(e). Our data disfavor 31% (5%) of the three-parameter space defined by δ, the octant of the θ23, and the mass hierarchy at the 68% (90%) C.L. We measure a value of 2sin(2)(2θ13)sin(2)(θ23) that is consistent with reactor experiments.
Collapse
|
136
|
Ke S, Wang W, Qiu X, Zhang F, T. Yustein J, G. Cameron A, Zhang S, Yu D, Zou C, Gao X, Lin J, Yallampalli S, Li M. Multiple Target-Specific Molecular Agents for Detection and Image Analysis of Breast Cancer Characteristics in Mice. Curr Mol Med 2013. [DOI: 10.2174/156652413805076849] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
137
|
Huang CX, Qiu X, Wang S, Wu H, Xia L, Li C, Gao Y, Zhang L, Xiu Y, Chao F, Tang Y. Exercise-induced changes of the capillaries in the cortex of middle-aged rats. Neuroscience 2013; 233:139-45. [DOI: 10.1016/j.neuroscience.2012.12.046] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2012] [Revised: 12/16/2012] [Accepted: 12/17/2012] [Indexed: 11/24/2022]
|
138
|
Yang S, Li C, Qiu X, Zhang L, Lu W, Chen L, Zhao Y, Shi X, Huang C, Cheng G, Tang Y. Effects of an enriched environment on myelin sheaths in the white matter of rats during normal aging: A stereological study. Neuroscience 2013; 234:13-21. [DOI: 10.1016/j.neuroscience.2013.01.003] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2012] [Revised: 12/25/2012] [Accepted: 01/03/2013] [Indexed: 11/25/2022]
|
139
|
Adamson P, Anghel I, Barr G, Bishai M, Blake A, Bock GJ, Bogert D, Cao SV, Childress S, Coelho JAB, Corwin L, Cronin-Hennessy D, de Jong JK, Devan AV, Devenish NE, Diwan MV, Escobar CO, Evans JJ, Falk E, Feldman GJ, Frohne MV, Gallagher HR, Gomes RA, Goodman MC, Gouffon P, Graf N, Gran R, Grzelak K, Habig A, Hartnell J, Hatcher R, Himmel A, Holin A, Hylen J, Irwin GM, Isvan Z, Jaffe DE, James C, Jensen D, Kafka T, Kasahara SMS, Koizumi G, Kopp S, Kordosky M, Kreymer A, Lang K, Ling J, Litchfield PJ, Lucas P, Mann WA, Marshak ML, Mathis M, Mayer N, McGowan AM, Medeiros MM, Mehdiyev R, Meier JR, Messier MD, Miller WH, Mishra SR, Moed Sher S, Moore CD, Mualem L, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nowak JA, O’Connor J, Oliver WP, Orchanian M, Pahlka RB, Paley J, Patterson RB, Pawloski G, Phan-Budd S, Plunkett RK, Qiu X, Radovic A, Rebel B, Rosenfeld C, Rubin HA, Sanchez MC, Schneps J, Schreckenberger A, Schreiner P, Sharma R, Sousa A, Tagg N, Talaga RL, Thomas J, Thomson MA, Toner R, Torretta D, Tzanakos G, Urheim J, Vahle P, Viren B, Weber A, Webb RC, White C, Whitehead L, Wojcicki SG, Zwaska R. Comparisons of annual modulations in MINOS with the event rate modulation in CoGeNT. Int J Clin Exp Med 2013. [DOI: 10.1103/physrevd.87.032005] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
140
|
Ke S, Zhang F, Wang W, Qiu X, Lin J, Cameron AG, Zou C, Gao X, Zou C, Zhu VF, Li M. Multiple target-specific molecular imaging agents detect liver cancer in a preclinical model. Curr Mol Med 2013; 12:944-51. [PMID: 22779431 PMCID: PMC3428706 DOI: 10.2174/156652412802480952] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2012] [Revised: 04/27/2012] [Accepted: 05/06/2012] [Indexed: 12/21/2022]
Abstract
Liver cancer is the fifth most common cause of cancer deaths worldwide. Noninvasive diagnosis is difficult and the disease heterogeneity reduces the accuracy of pathological assays. Improvement in diagnostic imaging of specific molecular disease markers has provided hope for accurate and early noninvasive detection of liver cancer. However, all current imaging technologies, including ultrasonography, computed tomography (CT), positron emission tomography (PET), and magnetic resonance imaging, are not specific targets for detection of liver cancer. The aim of this study was to test the feasibility of injecting a cocktail of specific molecular imaging agents to noninvasively image liver cancer. The target-specific cocktail contained agents for imaging the neovasculature (RGD peptide), matrix metalloproteinase (MMP), and glucose transport (18F-fluorodeoxyglucose [18F-FDG]). Imaging studies were performed in liver cancer cells and xenograft models. The distribution of MMP at the intracellular level was imaged by confocal microscopy. RGD, MMP, and 18F-FDG were imaged on tumor-bearing mice using PET, CT, X-ray, and multi-wavelength optical imaging modalities. Image data demonstrated that each agent bound to a specific disease target component. The same liver cancer xenograft contained multiple disease markers. Those disease markers were heterogenetically distributed in the same tumor nodule. The molecular imaging agents had different distributions in the whole body and inside the tumor nodule. All target-specific agents yielded high tumor-to-background ratios after injection. In conclusion, target-specific molecular imaging agents can be used to study liver cancer in vitro and in vivo. Noninvasive multimodal/multi-target-specific molecular imaging agents could provide tools to simultaneously study multiple liver cancer components.
Collapse
|
141
|
Liu Q, Wu K, Qiu X, Yang Y, Lin X, Yu M. siRNA silencing of gene expression in trabecular meshwork: RhoA siRNA reduces IOP in mice. Curr Mol Med 2013; 12:1015-27. [PMID: 22741561 DOI: 10.2174/156652412802480907] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2012] [Revised: 06/18/2012] [Accepted: 06/19/2012] [Indexed: 11/22/2022]
Abstract
Few reports described efficient transfection in the trabecular meshwork (TM) in vivo. In the present study, we investigated the distribution of cy3-labeled siRNAs after giving injection into the anterior chamber (AC) and explored the use of RhoA siRNA (siRhoA) to modulate intraocular pressure (IOP) through downregulation of RhoA gene and protein expression. Cy3-labeled siRNAs were injected into the AC to investigate the distribution. In addition, siRhoA was applied to normal and DEX-induced elevated IOP mice. The RhoA gene was detected at 1d post-injection (PI) using real-time RT-PCR. Proteins were examined using immunofluorescence staining at 1, 2, and 3 day PI. IOP was measured pre- and post-injection using a TONOPEN. Toxicity was preliminarily assessed using clinical observation and hematoxylin-eosin staining. The study demonstrated that cy3-labeled siRNAs accumulated in mouse TM in a dose-dependent manner, with a peak at 24h PI. There was no visible siRNA fluorescence in the corneal endothelium, and little in the iris. siRhoA caused large decreases in RhoA mRNA and protein expression in mouse TM (p < 0.01). In normal mice, injections of siRhoA induced decreases in IOP, by 2d, with recovery to baseline by 3d PI. For DEX-treated animals, IOP significantly decreased from 2d to 5d PI (p < 0.05). There was no obvious toxicity after the siRhoA application. These results suggest that (1) siRNA injection into the AC leads to transient gene transfection in TM; (2) inhibiting RhoA expression in TM with siRNA is effective in suppressing elevated IOP in mice, suggesting that siRhoA is a potential pharmaceutical intervention for glaucoma.
Collapse
|
142
|
Ferretti L, Qiu X, Fandel T, Zhang H, Banie L, Lin G, Lue T. Thérapie cellulaire pour maladie de Lapeyronie : effet des cellules souches dérivées des adipocytes sur un model animal. Prog Urol 2012. [DOI: 10.1016/j.purol.2012.08.149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
143
|
Qiu X, Guo S, Wu H, Chen J, Zhou Q. Identification of Wnt pathway, uPA, PAI-1, MT1-MMP, S100A4 and CXCR4 associated with enhanced metastasis of human large cell lung cancer by DNA microarray. Minerva Med 2012; 103:151-164. [PMID: 22653095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
AIM The aim of this paper was to investigate the differentially expressed genes in large cell lung cancer cell lines with different metastatic potential, and to screen out new candidate genes related to metastasis of lung cancer. METHODS The total RNAs of low and high metastatic large cell lung cancer cell lines (NL9980 and L9981) were extracted and processed, then hybridized to Affymetrix HG U133 Plus 2.0 array. The hybridization signals were scanned and compared to find out the differentially expressed genes. Chosen genes were verified by Western Blot. Bioinformatics were used to analyze the functions and related pathways of the genes. RESULTS There were 933 differentially expressed genes between NL9980 and L9981 cell lines. In the high metastatic cell line L9981, 672 genes were up-regulated and 260 genes were down-regulated compared with the low metastatic cell line NL9980. The differentially expressed genes were mainly associated with binding, catalytic activity, signal transducer activity and transporter activity, and mainly involved in pathways including, pathways in cancer, focal adhesion, regulation of actin cytoskeleton, ECM-receptor interaction. CONCLUSION Differentially expressed genes with the functions including binding, catalytic activity, signal transducer activity and transporter activity may promote metastasis of lung cancer cells through complicated networks including Wnt pathway and metastasis-related genes such as uPA, PAI-1, MT1-MMP, S100A4 and CXCR4.
Collapse
|
144
|
Adamson P, Ayres DS, Backhouse C, Barr G, Bishai M, Blake A, Bock GJ, Boehnlein DJ, Bogert D, Cao SV, Childress S, Coelho JAB, Corwin L, Cronin-Hennessy D, Danko IZ, de Jong JK, Devenish NE, Diwan MV, Escobar CO, Evans JJ, Falk E, Feldman GJ, Frohne MV, Gallagher HR, Gomes RA, Goodman MC, Gouffon P, Graf N, Gran R, Grzelak K, Habig A, Hartnell J, Hatcher R, Himmel A, Holin A, Huang X, Hylen J, Irwin GM, Isvan Z, Jaffe DE, James C, Jensen D, Kafka T, Kasahara SMS, Koizumi G, Kopp S, Kordosky M, Kreymer A, Lang K, Ling J, Litchfield PJ, Loiacono L, Lucas P, Mann WA, Marshak ML, Mathis M, Mayer N, Mehdiyev R, Meier JR, Messier MD, Michael DG, Miller WH, Mishra SR, Mitchell J, Moore CD, Mualem L, Mufson S, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nowak JA, Oliver WP, Orchanian M, Pahlka RB, Paley J, Patterson RB, Pawloski G, Phan-Budd S, Plunkett RK, Qiu X, Radovic A, Ratchford J, Rebel B, Rosenfeld C, Rubin HA, Sanchez MC, Schneps J, Schreckenberger A, Schreiner P, Sharma R, Sousa A, Strait M, Tagg N, Talaga RL, Thomas J, Thomson MA, Tinti G, Toner R, Torretta D, Tzanakos G, Urheim J, Vahle P, Viren B, Walding JJ, Weber A, Webb RC, White C, Whitehead L, Wojcicki SG, Zwaska R. Improved measurement of muon antineutrino disappearance in MINOS. PHYSICAL REVIEW LETTERS 2012; 108:191801. [PMID: 23003026 DOI: 10.1103/physrevlett.108.191801] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/13/2012] [Indexed: 06/01/2023]
Abstract
We report an improved measurement of ν(μ) disappearance over a distance of 735 km using the MINOS detectors and the Fermilab Main Injector neutrino beam in a ν(μ)-enhanced configuration. From a total exposure of 2.95×10(20) protons on target, of which 42% have not been previously analyzed, we make the most precise measurement of Δm2=[2.62(-0.28)(+0.31)(stat)±0.09(syst)]×10(-3) eV2 and constrain the ν(μ) mixing angle sin2(2θ)>0.75 (90% C.L.). These values are in agreement with Δm2 and sin2(2θ) measured for ν(μ), removing the tension reported in [P. Adamson et al. (MINOS), Phys. Rev. Lett. 107, 021801 (2011).].
Collapse
|
145
|
Fan H, Chen L, Zhang F, Quan Y, Su X, Qiu X, Zhao Z, Kong KL, Dong S, Song Y, Chan THM, Guan XY. MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma. Oncogene 2012; 31:2298-308. [PMID: 21909138 DOI: 10.1038/onc.2011.411] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2011] [Revised: 07/13/2011] [Accepted: 07/20/2011] [Indexed: 01/16/2023]
Abstract
DNA methyltransferase 3B (DNMT3B) mediates gene silencing via epigenetic mechanisms during hepatocellular carcinoma (HCC) progression. We aimed to identify novel targets of DNMT3B and their potential regulatory mechanisms in HCC. Metastasis suppressor 1 (MTSS1) was one of the DNMT3B targets and selected for further study. DNMT3B overexpression was detected in 81.25% of clinical HCC specimens and was negatively associated with MTSS1 in HCC cells and clinical samples. The underlying mechanism by which DNMT3B silences MTSS1 was studied using a combination of methylation-specific polymerase chain reaction (PCR) and bisulfite genome sequencing, chromatin immunoprecipitation-PCR and luciferase reporter assays. We found that the MTSS1 promoter region was sparsely methylated, and the methylation inhibitors failed to abolish DNMT3B-mediated MTSS1 silencing. DNMT3B protein bound directly to the 5'-flanking region (-865/-645) of the MTSS1 gene to inhibit its transcription. The functional role of MTSS1 was investigated using in vitro and in vivo tumorigenicity assays. As a result, MTSS1 exerted tumor suppressor effects and arrested cells in the G2/M phase, but not the G1/S phase of the cell cycle when it was depleted or overexpressed in HCC cells. Taken together, MTSS1, a novel target of DNMT3B, is repressed by DNMT3B via a DNA methylation-independent mechanism. MTSS1 was further characterized as a novel tumor suppressor gene in HCC. These findings highlight how DNMT3B regulates MTSS1, and such data may be useful for the development of new treatment options for HCC.
Collapse
|
146
|
Sun C, Lin H, Yu W, Li X, Chen Y, Qiu X, Wang R, Dai Y. Neurotrophic effect of bone marrow mesenchymal stem cells for erectile dysfunction in diabetic rats. ACTA ACUST UNITED AC 2012; 35:601-7. [PMID: 22428616 DOI: 10.1111/j.1365-2605.2012.01250.x] [Citation(s) in RCA: 55] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
It has been demonstrated that intracavernous injection of bone marrow-derived mesenchymal stem cells (BM-MSCs) had beneficial effects on improving erectile function in type-1 diabetic rats. This study was designed to investigate the neurotrophic effect of BM-MSCs for type-1 diabetic rats. Streptozocin-induced type-1 diabetic rats were randomly divided into three groups: diabetic group, BM-MSCs-treated group and BM-MSCs-conditioned medium-treated group. At the 3d, 1 and 2w time points after BM-MSCs injection, three randomly selected rats in MSCs group were sacrificed and penile samples were harvested to detect BM-MSCs in penile tissue. Four weeks after intracavernous injection of BM-MSCs or BM-MSCs-conditioned medium, intracavernous pressure (ICP) was assessed to evaluate the erectile function. Immunohistochemistry was used to track labelled BM-MSCs in penile tissue and to detect neuronal nitric oxide synthase (nNOS) and neurofilament (NF) positive fibres in penile dorsal nerve. Enzyme lined immunosorbent assay (ELISA) was used to measure the concentrations of vascular endothelial growth factor (VEGF), nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in BM-MSCs-conditioned medium. BM- MSCs secreted detectable levels of VEGF, BDNF and NGF. Intracavernous injection of BM-MSCs improved erectile function in diabetic rats. The functional improvement was accompanied by promoted nNOS and NF positive nerve fibres within penile dorsal nerve in type-1 diabetic rats. Histological data revealed a time-dependent decrease in the number of BM-MSCs in the corpus cavernosum following injection. Furthermore, the beneficial effect of BM-MSCs was partially repeated by BM-MSCs-conditioned medium. Intracavernous injection of BM-MSCs is effective in improving nerve regeneration in diabetic rats. Paracrine effects of BM-MSCs are probably involved in the improvement.
Collapse
|
147
|
Qiu X, Liu ZP. Recent developments of peptidomimetic HIV-1 protease inhibitors. Curr Med Chem 2012; 18:4513-37. [PMID: 21864279 DOI: 10.2174/092986711797287566] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2011] [Revised: 08/05/2011] [Accepted: 08/07/2011] [Indexed: 01/05/2023]
Abstract
HIV protease plays a crucial role in the viral life cycle by processing the viral Gag and Gag-Pol polyproteins into structural and functional proteins essential for viral maturation. Inhibition of HIV-1 protease leads to the production of noninfectious virus particles and hence is an important therapeutic target for antiviral therapy in AIDS patients. Among many strategies to combat this disease, highly active antiretroviral therapy (HAART) with HIV protease inhibitors (PIs) in combination with reverse transcriptase inhibitors and fusion inhibitor continues to be the first line treatment for control of HIV infection. However, the rapid emergence of drug-resistant HIV-1 strains and the appearance of cross-resistance are severely limiting the long-term treatment options. Thus, numerous efforts have been made in the design and synthesis of novel protease inhibitors with broad-spectrum activity against multidrug-resistant HIV-1 variants by medicinal chemists. This review will focus on the substrate-based drug design of novel peptidomimetic PIs in recent years since 2006.
Collapse
|
148
|
Hart RW, Mauk MG, Liu C, Qiu X, Thompson JA, Chen D, Malamud D, Abrams WR, Bau HH. Point-of-care oral-based diagnostics. Oral Dis 2011; 17:745-52. [PMID: 21521419 PMCID: PMC4273652 DOI: 10.1111/j.1601-0825.2011.01808.x] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
Many of the target molecules that reside in blood are also present in oral fluids, albeit at lower concentrations. Oral fluids are, however, relatively easy and safe to collect without the need for specialized equipment and training. Thus, oral fluids provide convenient samples for medical diagnostics. Recent advances in lab-on-a-chip technologies have made minute, fully integrated diagnostic systems practical for an assortment of point-of-care tests. Such systems can perform either immunoassays or molecular diagnostics outside centralized laboratories within time periods ranging from minutes to an hour. The article briefly reviews recent advances in devices for point-of-care testing with a focus on work that has been carried out by the authors as part of a NIH program.
Collapse
|
149
|
Adamson P, Auty DJ, Ayres DS, Backhouse C, Barr G, Betancourt M, Bishai M, Blake A, Bock GJ, Boehnlein DJ, Bogert D, Cao SV, Cavanaugh S, Cherdack D, Childress S, Coelho JAB, Corwin L, Cronin-Hennessy D, Danko IZ, de Jong JK, Devenish NE, Diwan MV, Dorman M, Escobar CO, Evans JJ, Falk E, Feldman GJ, Frohne MV, Gallagher HR, Gomes RA, Goodman MC, Gouffon P, Graf N, Gran R, Grzelak K, Habig A, Hartnell J, Hatcher R, Himmel A, Holin A, Huang X, Hylen J, Irwin GM, Isvan Z, Jaffe DE, James C, Jensen D, Kafka T, Kasahara SMS, Koizumi G, Kopp S, Kordosky M, Kreymer A, Lang K, Lefeuvre G, Ling J, Litchfield PJ, Loiacono L, Lucas P, Mann WA, Marshak ML, Mathis M, Mayer N, McGowan AM, Mehdiyev R, Meier JR, Messier MD, Michael DG, Miller WH, Mishra SR, Mitchell J, Moore CD, Mualem L, Mufson S, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nowak JA, Ochoa-Ricoux JP, Oliver WP, Orchanian M, Paley J, Patterson RB, Pawloski G, Pearce GF, Phan-Budd S, Plunkett RK, Qiu X, Ratchford J, Rebel B, Rosenfeld C, Rubin HA, Sanchez MC, Schneps J, Schreckenberger A, Schreiner P, Shanahan P, Sharma R, Sousa A, Tagg N, Talaga RL, Thomas J, Thomson MA, Toner R, Torretta D, Tzanakos G, Urheim J, Vahle P, Viren B, Walding JJ, Weber A, Webb RC, White C, Whitehead L, Wojcicki SG, Yang T, Zwaska R. Improved search for Muon-neutrino to electron-neutrino oscillations in MINOS. PHYSICAL REVIEW LETTERS 2011; 107:181802. [PMID: 22107623 DOI: 10.1103/physrevlett.107.181802] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/29/2011] [Indexed: 05/31/2023]
Abstract
We report the results of a search for ν(e) appearance in a ν(μ) beam in the MINOS long-baseline neutrino experiment. With an improved analysis and an increased exposure of 8.2 × 10(20) protons on the NuMI target at Fermilab, we find that 2 sin(2) (θ(23))sin(2)(2θ(13))<0.12(0.20) at 90% confidence level for δ = 0 and the normal (inverted) neutrino mass hierarchy, with a best-fit of 2sin(2) (θ(23))sin(2)(2θ(13)) = 0.041(-0.031)(+0.047) (0.079(-0.053) (+0.071)). The θ(13) = 0 hypothesis is disfavored by the MINOS data at the 89% confidence level.
Collapse
|
150
|
Adamson P, Auty DJ, Ayres DS, Backhouse C, Barr G, Bishai M, Blake A, Bock GJ, Boehnlein DJ, Bogert D, Cao SV, Cavanaugh S, Cherdack D, Childress S, Choudhary BC, Coelho JAB, Coleman SJ, Corwin L, Cronin-Hennessy D, Danko IZ, de Jong JK, Devenish NE, Diwan MV, Dorman M, Escobar CO, Evans JJ, Falk E, Feldman GJ, Frohne MV, Gallagher HR, Gomes RA, Goodman MC, Gouffon P, Graf N, Gran R, Grant N, Grzelak K, Habig A, Hartnell J, Hatcher R, Himmel A, Holin A, Howcroft C, Huang X, Hylen J, Irwin GM, Isvan Z, Jaffe DE, James C, Jensen D, Kafka T, Kasahara SMS, Koizumi G, Kopp S, Kordosky M, Kreymer A, Lang K, Lefeuvre G, Ling J, Litchfield PJ, Loiacono L, Lucas P, Mann WA, Marshak ML, Mathis M, Mayer N, Mehdiyev R, Meier JR, Messier MD, Michael DG, Miller WH, Mishra SR, Mitchell J, Moore CD, Mualem L, Mufson S, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nowak JA, Ochoa-Ricoux JP, Oliver WP, Orchanian M, Pahlka R, Paley J, Patterson RB, Pawloski G, Pearce GF, Phan-Budd S, Plunkett RK, Qiu X, Ratchford J, Rebel B, Rosenfeld C, Rubin HA, Sanchez MC, Schneps J, Schreckenberger A, Schreiner P, Sharma R, Sousa A, Strait M, Tagg N, Talaga RL, Tavera MA, Thomas J, Thomson MA, Tinti G, Toner R, Torretta D, Tzanakos G, Urheim J, Vahle P, Viren B, Walding JJ, Weber A, Webb RC, White C, Whitehead L, Wojcicki SG, Yang T, Zwaska R. Search for the disappearance of muon antineutrinos in the NuMI neutrino beam. Int J Clin Exp Med 2011. [DOI: 10.1103/physrevd.84.071103] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|